Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria.
about
Guideline of Chronic Urticaria BeyondPosition statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patientsSystematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatments.Treating chronic spontaneous urticaria using a brief 'whole person' treatment approach: a proof-of-concept studyCost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria.Retrospective analysis of the efficacy of omalizumab in chronic refractory urticariaChronic urticaria: Indian context-challenges and treatment options.EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders.Current challenges and controversies in the management of chronic spontaneous urticaria.Therapy of antihistamine-resistant chronic spontaneous urticaria.Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian population.Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome.The potential role of omalizumab in the treatment of chronic urticaria.Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema.Effective treatment of different phenotypes of chronic urticaria with omalizumab: Case reports and review of literature.Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice.Does omalizumab modify a course of recalcitrant chronic spontaneous urticaria?: A retrospective study in Asian patients.Serial D-dimer plasma levels in a patient with chronic spontaneous urticaria developing resistance to omalizumab.Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.
P2860
Q26743369-9B9F97E1-4F84-4295-8F57-95955E6FA68DQ26767180-B07572DF-1A54-4039-81BE-DE72FCC53FAAQ34454209-34D201B7-4E52-485A-8979-F2D6F05C6C6EQ36340754-6312EE7F-111D-4FD3-B435-0CC85765821DQ37056739-B92C1DFD-F666-438A-9FDE-8FC90B83804DQ37121967-1C287EF5-3F96-4208-976F-C5EF0A6A44E2Q37239677-7212CA0B-0C4E-4F9A-AAFB-8C101C4E9E09Q38394577-599DE41F-0FEB-4223-9834-F48A6F101036Q38547047-9E7E1A6C-1AC8-498B-A75E-002E089A2264Q38981770-250BEC3F-F48E-448E-B37B-734BC0DC9971Q39624099-35358585-35F9-44F7-9ED1-E15DB538910CQ41507426-9327F541-30D9-4199-9F0A-ECB080379A19Q41755302-4875BC9F-BF47-476D-BF86-B17D29651EC9Q42753216-4F7BD37F-A86D-4E0A-9401-C9F66B3DD5CFQ43470423-E4ED91F0-080E-40AD-B184-446633D242CFQ47960148-EDFD5DE2-4791-49B6-8BA1-912505EECA9DQ48169089-F4E02B48-DB5D-4183-85F2-0D0343B4AAB4Q53733505-FAFF057F-58BD-407B-BBA1-D8E514A2DE9EQ55429844-6C3138D6-F617-4664-B2CA-87FD42D62D13
P2860
Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Long-term efficacy of fixed-do ...... chronic spontaneous urticaria.
@en
Long-term efficacy of fixed-do ...... chronic spontaneous urticaria.
@nl
type
label
Long-term efficacy of fixed-do ...... chronic spontaneous urticaria.
@en
Long-term efficacy of fixed-do ...... chronic spontaneous urticaria.
@nl
prefLabel
Long-term efficacy of fixed-do ...... chronic spontaneous urticaria.
@en
Long-term efficacy of fixed-do ...... chronic spontaneous urticaria.
@nl
P2093
P1476
Long-term efficacy of fixed-do ...... chronic spontaneous urticaria.
@en
P2093
Christine Hahjin Song
Gordon L Sussman
Mohana Giruparajah
Noam Berlin
Simon Stern
P304
P356
10.1016/J.ANAI.2012.11.022
P577
2012-12-20T00:00:00Z